









市場行情
/
股票
/
nasdaq-dxcm
/

Dexcom Inc

DXCM

66.060USD

+0.150+0.23%

收盤 12/19, 16:00（美東）報價延遲15分鐘

25.76B總市值

35.86本益比TTM



Dexcom Inc

66.060

+0.150+0.23%

概覽公司財務分析

概覽

公司

財務

分析

關於 Dexcom Inc 公司

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Dexcom Inc簡介



公司代碼DXCM

公司名稱Dexcom Inc

上市日期Apr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

員工數量10300

證券類型Ordinary Share

年結日Apr 14

公司地址6340 Sequence Drive

城市SAN DIEGO

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編92121

電話18582000200

網址https://www.dexcom.com/

公司代碼DXCM

上市日期Apr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

Dexcom Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

294.46K

+6.59%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-12.01%

Ms. Bridgette P. Heller

Independent Director

27.03K

-3.61%

Mr. Kyle Malady

Independent Director

22.67K

-2.86%

Ms. Rimma Driscoll

Independent Director

9.04K

+127.87%

Ms. Renee D. Gala

Independent Director

6.88K

+20.30%

名稱

名稱/職務

職務

持股

持股變動

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

294.46K

+6.59%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-12.01%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Distributor

977.80M

84.50%

Direct

179.30M

15.50%

地區USD

名稱

營收

佔比

United States

841.00M

72.68%

Outside of United states

316.10M

27.32%

業務

地區

業務USD

名稱

營收

佔比

Distributor

977.80M

84.50%

Direct

179.30M

15.50%

股東統計

更新時間: 11月18日週二

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

12.63%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

4.07%

Geode Capital Management, L.L.C.

2.81%

其他

69.92%

持股股東

佔比

The Vanguard Group, Inc.

12.63%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

4.07%

Geode Capital Management, L.L.C.

2.81%

其他

69.92%

股東類型

持股股東

佔比

Investment Advisor

53.37%

Investment Advisor/Hedge Fund

28.82%

Hedge Fund

7.32%

Research Firm

4.05%

Pension Fund

2.14%

Bank and Trust

1.94%

Sovereign Wealth Fund

1.61%

Venture Capital

0.48%

Individual Investor

0.37%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

2120

388.08M

103.93%

+205.32K

2025Q3

2198

388.02M

104.56%

+4.65M

2025Q2

2236

383.14M

106.39%

+1.38M

2025Q1

2227

382.03M

104.52%

-27.81M

2024Q4

2209

376.25M

104.20%

-2.27M

2024Q3

2125

380.57M

105.64%

-16.02M

2024Q2

2097

395.55M

99.88%

+7.96M

2024Q1

2075

388.09M

102.93%

-19.55M

2023Q4

2061

396.17M

102.99%

+6.26M

2023Q3

1969

388.25M

103.58%

-414.67K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

48.15M

12.28%

+859.71K

+1.82%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

24.25M

6.18%

-475.12K

-1.92%

Jun 30, 2025

State Street Investment Management (US)

16.86M

4.3%

+175.27K

+1.05%

Jun 30, 2025

Baillie Gifford & Co.

16.71M

4.26%

+2.53M

+17.81%

Jun 30, 2025

Geode Capital Management, L.L.C.

10.77M

2.75%

+358.62K

+3.45%

Jun 30, 2025

Jennison Associates LLC

11.52M

2.94%

+994.30K

+9.45%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

8.03M

2.05%

-28.35K

-0.35%

Aug 31, 2025

Nuveen LLC

7.30M

1.86%

-549.07K

-7.00%

Jun 30, 2025

MFS Investment Management

6.49M

1.65%

+3.30M

+103.55%

Jun 30, 2025

持股ETF



更新時間: 12月2日週二

機構名稱

佔比

Global X Internet of Things ETF

3.86%

iShares U.S. Medical Devices ETF

2.71%

Motley Fool Global Opportunities ETF

1.9%

First Trust Growth Strength ETF

1.74%

Putnam Sustainable Future ETF

1.61%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

1.51%

Invesco S&P 500 Equal Weight Health Care ETF

1.25%

Direxion NASDAQ-100 Equal Weighted Index Shares

0.83%

First Trust NASDAQ 100 Equal Weighted Index Fund

0.83%

iShares Russell Mid-Cap Growth ETF

0.7%

Global X Internet of Things ETF

佔比3.86%

iShares U.S. Medical Devices ETF

佔比2.71%

Motley Fool Global Opportunities ETF

佔比1.9%

First Trust Growth Strength ETF

佔比1.74%

Putnam Sustainable Future ETF

佔比1.61%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

佔比1.51%

Invesco S&P 500 Equal Weight Health Care ETF

佔比1.25%

Direxion NASDAQ-100 Equal Weighted Index Shares

佔比0.83%

First Trust NASDAQ 100 Equal Weighted Index Fund

佔比0.83%

iShares Russell Mid-Cap Growth ETF

佔比0.7%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

Mar 28, 2022

Split

1→4

公告日期

類型

比率

Mar 28, 2022

Split

1→4

常見問題

Dexcom Inc的前五大股東是誰？



Dexcom Inc的前五大股東如下：
The Vanguard Group, Inc.
持有股份：48.15M
佔總股份比例：12.28%。
BlackRock Institutional Trust Company, N.A.
持有股份：24.25M
佔總股份比例：6.18%。
State Street Investment Management (US)
持有股份：16.86M
佔總股份比例：4.30%。
Baillie Gifford & Co.
持有股份：16.71M
佔總股份比例：4.26%。
Geode Capital Management, L.L.C.
持有股份：10.77M
佔總股份比例：2.75%。